American Beacon Stephens Sm Cp Gr R5 holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.
American Beacon Stephens Small Cap Growth Fund R5 Class STSIX
- NAV / 1-Day Return 17.53 / +1.15 %
- Total Assets 533.0M
-
Adj. Expense Ratio
0.990%
- Expense Ratio 1.000%
- Distribution Fee Level High
- Share Class Type Retirement, Large
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 250,000
- Status Open
- TTM Yield 0.00
- Turnover 35%
USD | NAV as of Oct 03, 2026 | 1-Day Return as of Oct 03, 2026, 12:11 AM GMT+0
Morningstar’s Analysis STSIX
Will STSIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 18.5
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Halozyme Therapeutics Inc | 2.03 | 11M | Healthcare |
Ligand Pharmaceuticals Inc | 1.99 | 11M | Healthcare |
Repligen Corp | 1.93 | 10M | Healthcare |
FirstCash Holdings Inc | 1.91 | 10M | Financial Services |
Xometry Inc Ordinary Shares - Class A | 1.88 | 10M | Industrials |
Travere Therapeutics Inc Ordinary Shares | 1.84 | 10M | Healthcare |
EZCORP Inc Registered Shs -A- Non Vtg | 1.77 | 9M | Financial Services |
Manhattan Associates Inc | 1.76 | 9M | Technology |
Twist Bioscience Corp | 1.73 | 9M | Healthcare |
U.S. Government Money Market S | 1.71 | 9M | Cash and Equivalents |